Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 93%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,075
Total Claims
$1.1M
Drug Cost
405
Beneficiaries
$2,605
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-89%
Opioid rate vs peers
0.4% vs 3.8% avg
+122%
Cost per patient vs peers
$2,605 vs $1,174 avg
+66%
Brand preference vs peers
14.7% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.4%
Opioid Rate
33
Opioid Claims
$94
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,180 claims · $940K
Generic: 6,855 claims · $112K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 136 | $169K |
| Dulaglutide | 89 | $115K |
| Empagliflozin | 104 | $89K |
| Paliperidone Palmitate | 20 | $68K |
| Linaclotide | 65 | $55K |
| Apixaban | 45 | $45K |
| Tirzepatide | 22 | $42K |
| Dapagliflozin Propanediol | 51 | $41K |
| Sitagliptin Phosphate | 49 | $38K |
| Budesonide/Formoterol Fumarate | 60 | $31K |
| Rivaroxaban | 23 | $21K |
| Fluticasone/Umeclidin/Vilanter | 23 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 36 | $18K |
| Finerenone | 13 | $11K |
| Insulin Degludec | 13 | $9,424 |
Prescribing Profile
Patient Profile
64
Avg Age
54%
Female
1.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About